Wisam Nabeel Ibrahim

992 total citations
40 papers, 644 citations indexed

About

Wisam Nabeel Ibrahim is a scholar working on Molecular Biology, Oncology and Complementary and alternative medicine. According to data from OpenAlex, Wisam Nabeel Ibrahim has authored 40 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Complementary and alternative medicine. Recurrent topics in Wisam Nabeel Ibrahim's work include Curcumin's Biomedical Applications (5 papers), Nigella sativa pharmacological applications (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). Wisam Nabeel Ibrahim is often cited by papers focused on Curcumin's Biomedical Applications (5 papers), Nigella sativa pharmacological applications (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). Wisam Nabeel Ibrahim collaborates with scholars based in Qatar, Malaysia and Iraq. Wisam Nabeel Ibrahim's co-authors include Abd Almonem Doolaanea, Siti Aslina Hussain, Hamid Ali Nagi Al‐Jamal, Wan Rohani Wan Taib, Muhammad Farid Johan, Jaya Kumar, Wael Mohamed, Syed Mahmood, Norlinah Mohamed Ibrahim and Mothanna Al-Qubaisi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Wisam Nabeel Ibrahim

37 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wisam Nabeel Ibrahim Qatar 15 176 105 103 78 73 40 644
Dileep Kumar India 22 405 2.3× 69 0.7× 129 1.3× 71 0.9× 86 1.2× 79 1.2k
Kuan Liu China 12 430 2.4× 45 0.4× 99 1.0× 109 1.4× 85 1.2× 29 1.0k
Phil‐Sun Oh South Korea 20 314 1.8× 55 0.5× 84 0.8× 77 1.0× 94 1.3× 62 952
Rishi Kant Singh India 14 182 1.0× 95 0.9× 34 0.3× 33 0.4× 62 0.8× 37 655
Pingping Gan China 13 288 1.6× 88 0.8× 76 0.7× 131 1.7× 51 0.7× 27 787
Vitale Del Vecchio Italy 16 273 1.6× 98 0.9× 136 1.3× 25 0.3× 46 0.6× 30 731
Jaung Geng Lin Taiwan 13 297 1.7× 160 1.5× 55 0.5× 29 0.4× 37 0.5× 20 700
Jie Qiu China 17 304 1.7× 30 0.3× 64 0.6× 41 0.5× 61 0.8× 60 987
Jiunn‐Kae Chang Taiwan 13 361 2.1× 66 0.6× 71 0.7× 98 1.3× 25 0.3× 14 818

Countries citing papers authored by Wisam Nabeel Ibrahim

Since Specialization
Citations

This map shows the geographic impact of Wisam Nabeel Ibrahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wisam Nabeel Ibrahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wisam Nabeel Ibrahim more than expected).

Fields of papers citing papers by Wisam Nabeel Ibrahim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wisam Nabeel Ibrahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wisam Nabeel Ibrahim. The network helps show where Wisam Nabeel Ibrahim may publish in the future.

Co-authorship network of co-authors of Wisam Nabeel Ibrahim

This figure shows the co-authorship network connecting the top 25 collaborators of Wisam Nabeel Ibrahim. A scholar is included among the top collaborators of Wisam Nabeel Ibrahim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wisam Nabeel Ibrahim. Wisam Nabeel Ibrahim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ibrahim, Wisam Nabeel, et al.. (2025). Gut Microbiota–Tumor Microenvironment Interactions: Mechanisms and Clinical Implications for Immune Checkpoint Inhibitor Efficacy in Cancer. PubMed Central. Volume 17. 171–192. 9 indexed citations
2.
3.
Anjum, Sumaira, et al.. (2025). Selenium Nanoparticles in Cancer Therapy: Unveiling Cytotoxic Mechanisms and Therapeutic Potential. Cancer Reports. 8(6). e70210–e70210. 4 indexed citations
4.
Irfan, Mohammad, et al.. (2025). Exploring TGF-β Signaling in Cancer Progression: Prospects and Therapeutic Strategies. OncoTargets and Therapy. Volume 18. 233–262. 11 indexed citations
5.
Ibrahim, Wisam Nabeel, et al.. (2025). The role of the microbiome in endometrial carcinoma: Pathogenesis, biomarkers, and therapeutic prospects. Journal of obstetrics and gynaecology research. 51(9). e70070–e70070. 2 indexed citations
6.
Abdallah, Atiyeh M., et al.. (2025). Role of Exosome in Solid Cancer Progression and Its Potential Therapeutics in Cancer Treatment. Cancer Medicine. 14(9). e70941–e70941. 3 indexed citations
7.
Ibrahim, Wisam Nabeel, et al.. (2024). Breaking Barriers: The Promise and Challenges of Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer. Biomedicines. 12(2). 369–369. 17 indexed citations
8.
Ibrahim, Wisam Nabeel, et al.. (2024). Impact of the MIF -173G/C variant on cardiovascular disease risk: a meta-analysis of 9,047 participants. Frontiers in Cardiovascular Medicine. 11. 1323423–1323423. 1 indexed citations
9.
Mohamed, Mahmoud H. A., et al.. (2024). Curcumin as a novel therapeutic candidate for cancer: can this natural compound revolutionize cancer treatment?. Frontiers in Oncology. 14. 1438040–1438040. 19 indexed citations
10.
11.
Ibrahim, Wisam Nabeel, et al.. (2023). Cancer Resistance to Immunotherapy: Comprehensive Insights with Future Perspectives. Pharmaceutics. 15(4). 1143–1143. 68 indexed citations
12.
Ibrahim, Wisam Nabeel, et al.. (2023). The Immunomodulatory Role of Microbiota in Rheumatic Heart Disease: What Do We Know and What Can We Learn from Other Rheumatic Diseases?. Medicina. 59(9). 1629–1629. 1 indexed citations
13.
Ibrahim, Wisam Nabeel, et al.. (2022). COVID-19 Vaccine Acceptance among Vulnerable Groups: Syrian Refugees in Jordan. Vaccines. 10(10). 1634–1634. 18 indexed citations
14.
Al-Qubaisi, Mothanna, Fatah H. Alhassan, Samer Hasan Hussein‐Al‐Ali, et al.. (2022). Preparation, characterization, in vitro drug release and anti-inflammatory of thymoquinone-loaded chitosan nanocomposite. Saudi Pharmaceutical Journal. 30(4). 347–358. 14 indexed citations
15.
Ibrahim, Wisam Nabeel, et al.. (2021). A Cross-Sectional Study on Bullying and Psychological Disturbances among Malaysian School Children. SHILAP Revista de lepidopterología. 25(1). 3 indexed citations
16.
Hussain, Siti Aslina, Mothanna Al-Qubaisi, Hakim Belkhalfa, et al.. (2021). Curcumin gum Arabic nanoparticles demonstrate potent antioxidant and cytotoxic properties in human cancer cells. Biocell. 46(3). 677–687. 3 indexed citations
17.
Doolaanea, Abd Almonem, et al.. (2021). The Promise of the Zebrafish Model for Parkinson’s Disease: Today’s Science and Tomorrow’s Treatment. Frontiers in Genetics. 12. 655550–655550. 50 indexed citations
18.
19.
Ibrahim, Wisam Nabeel, et al.. (2016). Expression of Collagenases Matrix Metalloproteinases and YB-1 Oncogenic Factor in Malignant Melanoma Cancer Cells and its Regulation by Stromal Fibroblasts. International Journal of Cancer Research. 13(1). 17–25. 1 indexed citations
20.
Liu, P., et al.. (2015). A Numerical Study on the Improving Techniques of the Cooling Performance of a Natural Draft Dry Cooling Tower under Crosswind. SHILAP Revista de lepidopterología. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dileep Kumar Breakdown of academic impact, for papers by Kuan Liu Breakdown of academic impact, for papers by Phil‐Sun Oh Breakdown of academic impact, for papers by Rishi Kant Singh Breakdown of academic impact, for papers by Pingping Gan Breakdown of academic impact, for papers by Vitale Del Vecchio Breakdown of academic impact, for papers by Jaung Geng Lin Breakdown of academic impact, for papers by Jie Qiu Breakdown of academic impact, for papers by Jiunn‐Kae Chang
Rankless by CCL
2026